Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)
Clinical trial NCT05533203 · UNKNOWN
Trial details
- NCT number
- NCT05533203
- Sponsor
- Shanghai Humantech Biotechnology Co. Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-08
- Primary completion
- 2023-08-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.